Latest Mergers And Acquisitions News

360 Capital REIT (ASX, TOT) reported a modest statutory net profit for FY25 and projects a fully tax-deferred distribution yield of 7.6% for FY26, underpinned by a modern, well-leased portfolio and strategic growth initiatives.

Bass Oil reported steady oil production in July alongside progress in acquiring the Vanessa gas field and advancing deep coal commercialisation efforts.

Regal Asian Investments Limited posted a sharp 92% decline in net profit for FY25 amid volatile Asian markets but maintained a fully franked 6 cent dividend and continued its on-market share buy-back program.

Kogan.com has recorded a significant non-cash goodwill impairment related to its Mighty Ape acquisition, reflecting ongoing challenges in New Zealand’s retail market and delayed technology recovery.

Pacgold Limited advances its Northern Queensland footprint with a maiden 900,000-ounce gold resource at Alice River and a new high-grade antimony acquisition at St George, positioning itself amid critical mineral supply challenges.

Pacgold Limited has entered a farm-in agreement to acquire up to 100% of the St George Gold-Antimony Project in North Queensland, unlocking exposure to a critical mineral with soaring prices and strong geopolitical demand.

360 Capital REIT (ASX – TOT) has reported a return to profitability in FY25, extending its debt facility and completing key leasing deals, while preparing for leasing challenges in FY26.

CuFe Ltd announces a remarkable 400% increase in its Gecko copper-gold resource at Tennant Creek, boosting the total project resource to 24.3 million tonnes. This comprehensive update integrates decades of historical data and expands the deposit’s economic potential with byproduct metals.

Highfield Resources faces a setback as China Minmetals and its subsidiary withdraw from a key strategic investment, triggering the maturity of convertible notes and raising questions about the future financing of the Muga potash project.

Power Minerals reports compelling high-grade niobium and rare earth element intersections from early-stage auger drilling at its Santa Anna Project in Brazil, extending the known mineralised footprint and reinforcing confidence in a significant resource.

Rhythm Biosciences has announced a $3.75 million placement to accelerate the commercial launch of its ColoSTAT® cancer detection test and expand its geneType™ product suite into key markets. The capital raise includes director participation and attaching options, pending shareholder approval.

Rhythm Biosciences is raising up to $3.75 million through a share placement to fund the launch of its ColoSTAT® colorectal cancer diagnostic and accelerate commercialization of its geneType™ portfolio.